Percy H. Carter

3.6k citations

59 papers · 1.5k indexed · h-index 23

Co-authors: Thomas J. Gardella David A. Evans Joëlle Prunet Erick M. Carreira André B. Charette Mark Lautens Michael D. Luck Masaru Shimizu
Topics: Chemokine receptors and signaling (20 papers)Chemical Synthesis and Analysis (12 papers)Immune Cell Function and Interaction (11 papers)
Cited by: Organic Chemistry Oncology Biotechnology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States Germany Sweden

In The Last Decade

Percy H. Carter

59 papers receiving 1.4k citations

Peers

Countries citing papers authored by Percy H. Carter

Since Specialization

Citations

This map shows the geographic impact of Percy H. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Percy H. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Percy H. Carter more than expected).

Fields of papers citing papers by Percy H. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Percy H. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Percy H. Carter. The network helps show where Percy H. Carter may publish in the future.

Co-authorship network of co-authors of Percy H. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Percy H. Carter. A scholar is included among the top collaborators of Percy H. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Percy H. Carter. Percy H. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9) 2020 ·ACS Medicinal Chemistry Letters ·(unknown),Dharmpal S. Dodd,(unknown),(unknown),Honghe Wan,Shana Posy,David Critton,Stefan Ruepp,Murali Subramanian,Andrew J. Watson,Paul Davies,Gary L. Schieven,Luisa Salter–Cid,Ratika Srivastava,Debarati M. Tagore,Shailesh Dudhgaonkar,Michael A. Poss,Percy H. Carter,Alaric J. Dyckman	30
2	Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists 2020 ·Bioorganic & Medicinal Chemistry Letters ·Bin Jiang,James J.‐W. Duan,(unknown),(unknown),(unknown),(unknown),Arun Kumar Gupta,Carolyn A. Weigelt,Javed Khan,John S. Sack,Dauh‐Rurng Wu,Melissa Yarde,(unknown),Michael A. Galella,Arvind Mathur,Qihong Zhao,Luisa Salter–Cid,Percy H. Carter,T. G. Murali Dhar	9
3	Discovery of 2,6–difluorobenzyl ether series of phenyl ((R)–3–phenylpyrrolidin–3–yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists 2020 ·Bioorganic & Medicinal Chemistry Letters ·James J.‐W. Duan,Bin Jiang,Zhonghui Lu,(unknown),Carolyn A. Weigelt,John S. Sack,Javed Khan,Max Ruzanov,Dauh‐Rurng Wu,Melissa Yarde,(unknown),Qihong Zhao,Luisa Salter–Cid,Percy H. Carter,T. G. Murali Dhar	4
4	Investigating investment in biopharmaceutical R&D 2016 ·DSpace@MIT (Massachusetts Institute of Technology) ·Percy H. Carter,Joseph A. DiMasi,Ernst R. Berndt,Mark Trusheim	3
5	Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Rajeev S. Bhide,(unknown),(unknown),Zheming Ruan,(unknown),Carolyn A. Weigelt,John S. Sack,Kevin Stefanski,Xiaomei Gu,Jenny Xie,(unknown),Stacey Skala,Donna L. Pedicord,Stefan Ruepp,T. G. Murali Dhar,Percy H. Carter,Luisa Salter–Cid,Michael A. Poss,Paul Davies	12
6	Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Qing Shi,(unknown),Douglas G. Batt,Michael A. Galella,(unknown),Rui‐Qin Liu,Feng Qiu,Qihong Zhao,Joel C. Barrish,Percy H. Carter	2
7	Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2) 2011 ·Bioorganic & Medicinal Chemistry Letters ·Michael G. Yang,Zili Xiao,Qing Shi,Robert J. Cherney,Andrew J. Tebben,George V. De Lucca,Joseph B. Santella,Ruowei Mo,Mary Ellen Cvijic,Qihong Zhao,Joel C. Barrish,Percy H. Carter	2
8	Clinically validated approaches to the treatment of autoimmune diseases 2010 ·Expert Opinion on Investigational Drugs ·Percy H. Carter,Qihong Zhao	21
9	Spiroindenes and spiroindanes as antagonists of CC chemokine receptor 2: WO 2009023754 2010 ·Expert Opinion on Therapeutic Patents ·Percy H. Carter	5
10	Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Robert J. Cherney,(unknown),Ruowei Mo,(unknown),Gengjie Yang,(unknown),Peggy Scherle,Bruce F. Molino,Percy H. Carter,Carl P. Decicco	15
11	Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe 2007 ·Proceedings of the National Academy of Sciences ·Percy H. Carter,Rui‐Qin Liu,William R. Foster,Joseph Tamasi,Andrew J. Tebben,Margaret Favata,Ada Staal,Mary Ellen Cvijic,M. H. French,(unknown),Donald Apanovitch,Ming Lei,Qihong Zhao,Mark Cunningham,Carl P. Decicco,James M. Trzăskos,Jean H.M. Feyen	22
12	From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Daniel S. Gardner,Joseph B. Santella,Andrew J. Tebben,Douglas G. Batt,Soo S. Ko,Sarah C. Traeger,(unknown),Eric Wadman,Paul Davies,Percy H. Carter,John V. Duncia	9
13	Capped diaminopropionamide–glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2) 2007 ·Bioorganic & Medicinal Chemistry Letters ·Percy H. Carter,(unknown),(unknown),Robert J. Cherney,Andrew J. Tebben,(unknown),Gengjie Yang,(unknown),Kimberly A. Solomon,Peggy Scherle,Carl P. Decicco	15
14	Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-Dependent tumor necrosis factor-α antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Matthew E. Voss,Percy H. Carter,Andrew J. Tebben,Peggy Scherle,(unknown),Lorin A. Thompson,Meizhong Xu,(unknown),Gengjie Yang,Rui‐Qin Liu,(unknown),(unknown),James M. Trzăskos,Carl P. Decicco	58
15	A new synthesis of cytoxazone and its diastereomers provides key initial SAR information 2003 ·Bioorganic & Medicinal Chemistry Letters ·Percy H. Carter,(unknown),Peggy Scherle,Carl P. Decicco	32
16	Chemokine receptor antagonism as an approach to anti-inflammatory therapy: ‘just right’ or plain wrong? 2002 ·Current Opinion in Chemical Biology ·Percy H. Carter	48
17	Zinc(II)-mediated enhancement of the agonist activity of histidine-substituted parathyroid hormone(1–14) analogues 2001 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Percy H. Carter,Thomas J. Gardella	4
18	Identification of Determinants of Inverse Agonism in a Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor by Photoaffinity Cross-linking and Mutational Analysis 2001 ·Journal of Biological Chemistry ·Robert Gensure,Percy H. Carter,(unknown),Harald Jüppner,Thomas J. Gardella	24
19	Autoactivation of Type-1 Parathyroid Hormone Receptors Containing a Tethered Ligand 2000 ·Journal of Biological Chemistry ·Masaru Shimizu,Percy H. Carter,Thomas J. Gardella	32
20	The (1–14) Fragment of Parathyroid Hormone (PTH) Activates Intact and Amino-Terminally Truncated PTH-1 Receptors 1999 ·Molecular Endocrinology ·Michael D. Luck,Percy H. Carter,Thomas J. Gardella	64

About Percy H. Carter

Percy H. Carter is a scholar working on Oncology, Immunology and Microbiology, having authored 59 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (20 papers), Chemical Synthesis and Analysis (12 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Organic Chemistry (630 citations), Oncology (444 citations) and Biotechnology (130 citations). Percy H. Carter has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Thomas J. Gardella, David A. Evans, Joëlle Prunet, Erick M. Carreira, André B. Charette, Mark Lautens, Michael D. Luck, Masaru Shimizu, Carl P. Decicco and Andrew J. Tebben. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact